Making sense of antisense

The yeast Candida albicans is the major pathogen causing human fungal infections. C. albicans is not amenable to functional genomic strategies used for other micro-organisms, because of mating difficulties, its diploid nature and the lack of random insertional mutagenesis methods.In March Nature Biotechnology Marianne De Backer and colleagues describe an approach to overcoming these limitations, in order to perform a genome-wide screen for gene function (Nature Biotechnology 2001, 19:235-241). T

By | March 8, 2001

The yeast Candida albicans is the major pathogen causing human fungal infections. C. albicans is not amenable to functional genomic strategies used for other micro-organisms, because of mating difficulties, its diploid nature and the lack of random insertional mutagenesis methods.

In March Nature Biotechnology Marianne De Backer and colleagues describe an approach to overcoming these limitations, in order to perform a genome-wide screen for gene function (Nature Biotechnology 2001, 19:235-241). The technique combines antisense RNA and promoter interference technology and involves the development of an integrative vector to drive transcription of antisense RNA in an inducible manner.

De Backer et al created a library of cloned C. albicans DNA fragments, introduced these into C. albicans and screened for the effects of gene suppression on yeast growth. About 10% of transformants showed a growth phenotype and it was possible to identify 86 different genes, of which 38% have no homologues in other organisms.

They also showed that these crippled strains could be used effectively in high-throughput screening assays to identify possible antifungal drugs. This is because reduced expression of a gene renders the yeast more sensitive to drugs that act on its protein product or associated molecules in the same pathway.

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech